OCULAR THERAPEUTIX, INC (OCUL) Form 8-K — Oct 16, 2026

$OCULForm 8-KItems 5.02Filed Oct 16, 2026, 4:15 PM ET0001104659-26-116617Original filing

Ocular Therapeutix disclosed that Chief Strategy Officer Sanjay Nayak resigned effective October 16, 2026, to become CEO of a privately-held company. The 8-K was filed under Item 5.02, and no successor has been named.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.